Literature DB >> 7799001

The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy.

A E Rosser1, J R Hodges.   

Abstract

The Dementia Rating Scale (DRS) comprises a series of five subtests which assess attention, memory, initiation/preservation, construction, and conceptualisation. It can be delivered in full in approximately 30 min, making it a useful test for the detection and estimation of the overall level of dementia. We analysed the pattern of subscale test scores in patients with cortical and subcortical dementias, who were matched for their overall level of dementia on this scale. Patients with dementia of Alzheimer's type were more impaired than patients with Huntington's disease (HD) and progressive supranuclear palsy (PSP) on the memory subtest, whereas patients with HD and PSP were more impaired on the initiation/perseveration subtest. This is evidence in favour of the concept of cortical and subcortical dementias as separate, although overlapping, entities. Qualitative differences in the pattern of cognitive impairment in these disorders can be detected with a brief cognitive status examination.

Entities:  

Mesh:

Year:  1994        PMID: 7799001     DOI: 10.1007/bf00873515

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  'Subcortical dementia': the neuropsychological evidence.

Authors:  R G Brown; C D Marsden
Journal:  Neuroscience       Date:  1988-05       Impact factor: 3.590

3.  Prefrontal cortical blood flow and cognitive function in Huntington's disease.

Authors:  D R Weinberger; K F Berman; M Iadarola; N Driesen; R F Zec
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-01       Impact factor: 10.154

4.  Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.

Authors:  J C Hedreen; C E Peyser; S E Folstein; C A Ross
Journal:  Neurosci Lett       Date:  1991-12-09       Impact factor: 3.046

5.  Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease.

Authors:  B Pillon; B Dubois; F Lhermitte; Y Agid
Journal:  Neurology       Date:  1986-09       Impact factor: 9.910

6.  Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

Authors:  S G Hasselbalch; G Oberg; S A Sørensen; A R Andersen; G Waldemar; J F Schmidt; K Fenger; O B Paulson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

7.  Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome.

Authors:  M B Moss; M S Albert; N Butters; M Payne
Journal:  Arch Neurol       Date:  1986-03

8.  Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory.

Authors:  N Butters; J Wolfe; M Martone; E Granholm; L S Cermak
Journal:  Neuropsychologia       Date:  1985       Impact factor: 3.139

9.  Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease.

Authors:  S Lehéricy; E C Hirsch; P Cervera; L B Hersh; J J Hauw; M Ruberg; Y Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease.

Authors:  N Butters; J Wolfe; E Granholm; M Martone
Journal:  Cortex       Date:  1986-03       Impact factor: 4.027

View more
  8 in total

Review 1.  Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

Authors:  Deborah A Hall; Maria João Forjaz; Lawrence I Golbe; Irene Litvan; Christine Ann M Payan; Christopher G Goetz; Albert F G Leentjens; Pablo Martinez-Martin; Anne Pavy-Le Traon; Cristina Sampaio; Bart Post; Glenn Stebbins; Daniel Weintraub; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2015-05-22

Review 2.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

Review 3.  Do Patients with Progressive Supranuclear Palsy Have Episodic Memory Impairment? A Systematic Review.

Authors:  Arthur Cassa Macedo; Luciano Inácio Mariano; Marina Isoni Martins; Clarisse Vasconcelos Friedlaender; Jesus Mística Ventura; João Victor de Faria Rocha; Sarah Teixeira Camargos; Francisco Eduardo Costa Cardoso; Paulo Caramelli; Leonardo Cruz de Souza
Journal:  Mov Disord Clin Pract       Date:  2022-04-04

4.  Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease.

Authors:  Katya Rascovsky; David P Salmon; Lawrence A Hansen; Douglas Galasko
Journal:  J Int Neuropsychol Soc       Date:  2008-05       Impact factor: 2.892

5.  Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Kevin Duff; Leigh J Beglinger; Danielle Theriault; Jessica Allison; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2009-05-29       Impact factor: 2.475

6.  The underlying mechanisms of verbal fluency deficit in frontotemporal dementia and semantic dementia.

Authors:  Mickaël Laisney; Vanessa Matuszewski; Florence Mézenge; Serge Belliard; Vincent de la Sayette; Francis Eustache; Béatrice Desgranges
Journal:  J Neurol       Date:  2009-04-14       Impact factor: 4.849

7.  Normative data for middle-aged Brazilians in the Mattis Dementia Rating Scale.

Authors:  Guilherme Almeida Carvalho; Paulo Caramelli
Journal:  Dement Neuropsychol       Date:  2020-12

8.  Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Shuxia Qian; Keliang Chen; Qiaobing Guan; Qihao Guo
Journal:  BMC Neurol       Date:  2021-04-21       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.